Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, October 14 at 2:00 PM ET

Register Free →

Search

Top

LITHOLINK CORPORATION

Subsidiary ofLABORATORY CORPORATION OF AMERICAUEI: K61XKD6NEGV7CAGE: 5BN00

LITHOLINK CORPORATION is a federal contractor, registered under UEI K61XKD6NEGV7 and CAGE code 5BN00. It has been awarded $377,944 in federal contracts. Primary work spans Medical Laboratories, Unknown NAICS, and Research and Development in Biotechnology (except Nanobiotechnology). Top awarding agencies include Department Of Health And Human Services and Department Of Veterans Affairs.

Contact Information

Registration and classification details

Phone+1 (555) 000-0000

Address123 Main St, City, ST 12345

Registration

UEI Code

K61XKD6NEGV7

CAGE Code

5BN00

Entity Structure

Corporate Entity (Not Tax Exempt)

Established

N/A

Business Classifications

For Profit Organization

NAICS Codes

621511Medical Laboratories(Primary)

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

AI Capability Profile

LithoLink Corporation specializes in biomedical research focused on the molecular mechanisms of kidney stone formation, with a demonstrated capability in identifying key proteins associated with calcium oxalate lithiasis. Their technical expertise lies in proteomic analysis, biomarker discovery, and...

Key Performance Metrics

Awards Count

21

All time

Active

0

Currently performing

Completed

21

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

Department Of Health And Human Services$216.7K57.4%Department Of Veterans Affairs$161.2K42.7%

Awards by NAICS

621511 - Medical Laboratories$273.4K72.3%

- Unknown NAICS$84.5K22.4%

541714 - Research and Development in Biotechnology (except Nanobiotechnology)$16.4K4.3%622110 - General Medical and Surgical Hospitals$3.6K1%

Awards by Agency Over Time

Awards by Place of Performance

Compete with LITHOLINK CORPORATION

Track the contractors you bid against, and the work they win

Award history, agency mix, and NAICS coverage for LITHOLINK CORPORATION

AI-powered matching against your own capabilities and past performance

Teaming and subcontracting signals on every award

Automated alerts when a competitor wins in your market

Join 750+ contractors already using CLEATUS

Open opportunities in LITHOLINK CORPORATION's top NAICS codes and agencies

Offsite Surgical Tray Reprocessing and SterilizationThis subcontract opportunity is for the offsite reprocessing and sterilization of reusable medical equipment and surgical trays supporting prime contractors at the VA Loma Linda Healthcare System. The selected provider will be responsible for the end-to-end decontamination, cleaning, inspection, and assembly of trays, ensuring all deliverables are ready for clinical use. All operations must strictly adhere to AAMI ST79, AAMI ST90, and VHA Directive 1116 standards, utilizing industrial autoclaves and critical water filtration systems in compliance with AAMI ST108. Managed by the Department of Veterans Affairs Network Contract Office 22, this project is designated as a total Small Business Set Aside under NAICS code 621511. The work will be performed in Loma Linda, California. Interested parties should note the response deadline of October 19, 2026.

262-NETWORK Contract Office 22 (36C262)

POSTED

DEADLINE

Comprehensive Medical ServicesThe Department of Justice, specifically the Federal Prison System under the Bureau of Prisons, is forecasting a requirement for Comprehensive Medical Services. This opportunity is categorized under NAICS code 622110 and is designated as Full and Open/Unrestricted, meaning it is available for competition among all qualified providers regardless of business size. The services will be performed in Sheridan, Oregon. Interested parties can coordinate with Lashundra D. Thomas as the primary point of contact or Sarah Dean for small business inquiries. Further details regarding this forecast are available through the Department of Justice contracting opportunities portal.

Federal Prison System / Bureau Of Prisons

POSTED

DEADLINE

Comprehensive Medical ServicesThe Department of Justice, specifically the Federal Prison System / Bureau of Prisons, is forecasting a requirement for Comprehensive Medical Services. This opportunity is categorized under NAICS code 622110 and is designated as Full and Open/Unrestricted, meaning it is available for competition among all qualified providers regardless of business size or set-aside status. The services will be performed in Oxford, Wisconsin. Interested parties can coordinate with Lashundra D. Thomas as the primary point of contact or Sarah Dean for small business inquiries. Further details regarding this forecast can be found through the Department of Justice contracting opportunities portal.

Federal Prison System / Bureau Of Prisons

POSTED

DEADLINE

Comprehensive Medical ServicesThe Department of Justice, specifically the Federal Prison System / Bureau of Prisons, is forecasting a requirement for Comprehensive Medical Services to be performed in El Reno, Oklahoma. This opportunity is categorized under NAICS code 622110 and is designated as Full and Open/Unrestricted, meaning it is available for competition among all qualified providers regardless of business size. The forecast was posted on October 11, 2026, and is managed through the Department of Justice. Interested parties can coordinate with Lashundra D. Thomas as the primary point of contact or Sarah Dean for small business inquiries. Further details regarding this procurement can be found via the Department of Justice forecast contracting opportunities portal.

Federal Prison System / Bureau Of Prisons

POSTED

DEADLINE

Q301-- New Lab Staffing Contract Fiscal Year 2027-Path & Lab

Solicitation # 36C24926Q0334_1

The Department of Veterans Affairs, Network Contracting Office 9, is soliciting quotes for a five-year Indefinite Delivery, Indefinite Quantity (IDIQ) contract to provide laboratory staffing services at the Lt. Col Luke Weathers Jr. VAMC in Memphis, Tennessee. The performance period runs from April 1, 2027, to March 31, 2032, with a total estimated value of 41.5 million dollars. This procurement is a 100 percent set-aside for Service-Disabled Veteran-Owned Small Businesses (SDVOSBs). The contractor is required to provide up to 16 full-time equivalent key personnel to support three daily shifts, with a guaranteed minimum of 3,402 hours and a maximum not to exceed 340,240 hours. Award will be based on a best-value determination using comparative analysis of administrative compliance, past performance, technical capability, and price. Technical evaluation specifically emphasizes the quality of certifications and the effectiveness of the contractor's contingency plan for ensuring uninterrupted services. Contractors must adhere to strict clinical standards, including JCAHO, CAP, FDA, and CLIA regulations, and comply with all VA security, confidentiality, and HIPAA requirements. Proposals must be submitted electronically by October 14, 2026, and must include specific certifications regarding the Immigration and Nationality Act, organizational conflicts of interest, and OIG exclusion lists.

249-NETWORK Contract Office 9 (36C249)

POSTED

DEADLINE

NWI Offsite Pathology Services

Solicitation # 36C26326R0063

Network Contract Office 23 (36C263)

POSTED

DEADLINE

High-Throughput Functional Genomic AssayingThis subcontract, titled High-Throughput Functional Genomic Assaying, supports National Institutes of Health and NHGRI research projects by providing experimental testing of genomic variants. The scope of work involves implementing high-throughput assays to perturb variants and executing functional interpretation strategies utilizing CRISPR-based systems and high-throughput screening platforms. The selected provider is responsible for delivering raw molecular and cellular data along with all associated metadata. The project is managed under the Department of Health and Human Services and requires strict adherence to 45 CFR Part 46 regulations regarding human subjects research. The opportunity was posted on October 9, 2026, with a response deadline of December 14, 2026. It is categorized under NAICS code 541714 for research and development in biotechnology.

National Institutes Of Health

POSTED

DEADLINE

Human Tissue Acquisition and Biobanking ServicesThe Human Tissue Acquisition and Biobanking Services subcontract, managed under the National Institutes of Health within the Department of Health and Human Services, focuses on the procurement, storage, and preservation of human tissues for senescence research projects. The selected provider is responsible for delivering cataloged, assay-ready specimens while utilizing ultra-low temperature freezers and liquid nitrogen to ensure sample integrity. Strict compliance is required regarding human subjects protection, confidentiality agreements, and the procurement of necessary IRB approvals. Interested parties must submit their responses by November 23, 2026, for this project categorized under NAICS code 621511.

National Institutes Of Health

POSTED

DEADLINE

in about 1 month

Specialized Phenotypic Assay Development/ExecutionThis subcontract, titled Specialized Phenotypic Assay Development/Execution, supports prime contractors on NIH IGVF Consortium projects under the Department of Health and Human Services. The primary objective is the collection of robust phenotypic data through the execution of imaging, proteomics, and transcriptomics assays designed to measure the impacts of variant interactions. To achieve this, the contractor will utilize advanced technical equipment, including mass spectrometers, flow cytometers, and high-content imaging systems. The scope of work emphasizes the delivery of high-quality phenotypic data sets while adhering to strict quality control standards for high-throughput data. This opportunity falls under NAICS code 541714 and was posted on October 9, 2026, with a response deadline of December 14, 2026.

National Institutes Of Health

POSTED

DEADLINE

Human Biospecimen Sourcing and CharacterizationThis subcontract for the National Institutes of Health involves the sourcing and characterization of human biospecimens to support Senescence Technologies projects. The selected provider will be responsible for procuring high-priority human tissue samples, processing them to ensure cellular integrity, and delivering the processed specimens along with essential characterization data and metadata for the SenNet Data Portal. To execute these requirements, the contractor must maintain robust cold chain logistics and biorepository capabilities while ensuring full HIPAA compliance and obtaining all necessary IRB approvals. This effort falls under NAICS code 621511 and requires a response by November 23, 2026.

National Institutes Of Health

POSTED

DEADLINE

in about 1 month

Senescence-Specific Reagent and Tool ManufacturingThis subcontract, titled Senescence-Specific Reagent and Tool Manufacturing, supports National Institutes of Health projects focused on senescence technologies. The selected provider will develop and supply innovative reagents, biospecimens, and tools for prime contractors, specifically focusing on the creation of markers for phenotypic identifiers and the manufacture of reagents to identify senescence heterogeneity within secretomes and tissue environments. The scope of work requires the use of biotechnology laboratory facilities for antibody production and protein synthesis, with a final delivery of validated assays and physical reagents. All operations must strictly adhere to NIH guidelines regarding human systems. The opportunity was posted on October 9, 2026, with a response deadline of November 23, 2026, falling under NAICS code 541714.

National Institutes Of Health

POSTED

DEADLINE

in about 1 month

Cellular Senescence Network (SenNet): SenNet Technology Projects (SenTecs) (UG3/UH3 Clinical Trial Not Allowed)

Solicitation # RFA-RM-27-007

The National Institutes of Health, under the Department of Health and Human Services, is soliciting the development or adaptation of innovative senescence technologies (SenTecs) through solicitation RFA-RM-27-007. These technologies aim to identify, characterize, and understand senescent cell heterogeneity within tissue environments and secretomes to improve strategies for modulating these cells in human aging and disease. The program utilizes a five-year, milestone-driven award structure divided into two phases: a two-year UG3 phase focused on development and feasibility, and a three-year UH3 phase dedicated to optimization, refinement, and validation. Transition to the UH3 phase is not automatic and requires an administrative review at the end of year two. The final year of the award requires a collaborative demonstration project within the SenNet consortium. The NIH intends to commit 5.4 million dollars in total costs for fiscal year 2027 to fund up to nine awards, with direct cost caps of 400,000 dollars per year for the UG3 phase and 550,000 dollars per year for the UH3 phase. Applications are evaluated based on the importance of the research, scientific rigor, feasibility, and the expertise of the investigators. Required submissions include an Intellectual Property Strategy and a Data Management and Sharing Plan. Awardees must adhere to strict cybersecurity incident reporting, maintain a seven-year confidentiality agreement for non-public information, and ensure all technical assets and data are deposited into the SenNet Data Portal. Clinical trials are not allowed under this specific opportunity.

National Institutes Of Health

POSTED

DEADLINE

in about 1 month

IGVF Data and Coordinating Center (U24 Clinical trials Not Allowed)

Solicitation # RFA-HG-27-008

The National Human Genome Research Institute (NHGRI), under the Department of Health and Human Services, is soliciting applications for the Impact of Genomic Variation on Function (IGVF) Data and Coordinating Center (DACC) via solicitation RFA-HG-27-008. The DACC will serve as the central hub for the IGVF Consortium, tasked with developing a comprehensive, searchable catalog of genomic function and variant impacts and managing a data portal for housing and sharing consortium resources. Key technical objectives include the hardening of data processing pipelines to ensure they are containerized, robust, and reproducible, while adopting existing data and metadata standards to promote interoperability. The NHGRI intends to commit 6 million dollars in total costs for the period of FY 2027-2031, with annual application budgets limited to 4 million dollars in direct costs. Funding decisions are based on scientific peer review and program-specific considerations, focusing on technical merit, synergy with other IGVF projects, and the applicant's capability to coordinate large-scale genomic data efforts. Applicants must maintain active registrations in SAM, eRA Commons, and Grants.gov, and all Principal Investigators must have a linked ORCID ID. Special requirements include a dedicated Project Manager devoting at least 6 person months and strict adherence to the Cybersecurity Act of 2015, which mandates reporting cybersecurity incidents within 48 hours of discovery. Proposals must include a Research Strategy limited to 30 pages and be submitted via an institutional system-to-system solution by the December 14, 2026, deadline.

National Institutes Of Health

POSTED

DEADLINE

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Solicitation # RFA-RM-27-016

The National Institutes of Health (NIH) is soliciting applications under RFA-RM-27-016 to establish SenNet Discovery and Validation Centers (DVCs) as part of Stage 2 of the Cellular Senescence Network. The primary objective of these centers is to define, refine, and validate tissue- and disease-relevant cellular senescence signatures, known as senotypes, and their associated biomarkers. DVCs are required to investigate the functional consequences of these signatures in human health and disease, generate high-quality molecular, cellular, and spatial datasets for public release via the Data Coordination and Informatics Center, and execute consortium-wide organizational and outreach activities. The maximum project period is five years, with application budgets limited to approximately 3 million dollars in direct costs per year. A specific requirement includes a mandatory 600,000 dollar annual direct cost allocation for the SenNet Organization and Outreach Component, of which 40 to 45 percent must support educational programs. Additionally, starting in Year 2, centers must set aside approximately 10 percent of their total budget for cross-consortium validation. Applications are evaluated through the NIH peer review system based on significance, approach, and the protection of human subjects, with performance measured annually by the successful acceptance and public release of data. Applicants must maintain active registrations in the System for Award Management and eRA Commons. Required submission materials include a 30-page application divided into four elements covering vision, preclinical modeling, biospecimen management, and outreach, along with letters of support and human subjects documentation where applicable. Awardees must adhere to strict data security protocols, including a seven-year confidentiality disclosure agreement and a requirement to report cybersecurity incidents within 48 hours.

National Institutes Of Health

POSTED

DEADLINE

in about 1 month

Systematic Characterization of Genomic Variation to Assess Effects of Individual Variants on Genome Function and Phenotype (UM1 Clinical Trials Not Allowed)

Solicitation # RFA-HG-27-007

The National Institutes of Health, through the Department of Health and Human Services, is soliciting applications under RFA-HG-27-007 to establish centers for the Impact of Genomic Variation on Function (IGVF) Consortium. The primary objective is to characterize genomic variation and assess how individual variants in DNA, RNA, or protein-coding elements impact genome function and phenotypes. Funded centers will utilize high-throughput methods to perturb variants, collect molecular and cellular data, and develop portable data processing pipelines. These centers are expected to collaborate within the consortium to coordinate assays and cell types, contributing raw and processed data to the IGVF Catalog via the Data Analysis and Coordination Center. The funding cycle runs from 2027 through fiscal year 2031, with a maximum project period of five years and budgets limited to 2 million dollars in direct costs per year. Notably, 20 percent of direct costs must be allocated to support collaborative work. Applications are evaluated based on scientific merit through the NIH peer review system and a second level of review by the National Advisory Council for Human Genome Research, focusing on significance, overall impact, and the utility of the proposed assays. Clinical trials are not allowed, and research involving human subjects must comply with 45 CFR Part 46. Applicants must maintain active registrations in the System for Award Management and eRA Commons, and all Principal Investigators must have a linked ORCID ID. Required submissions include a Research Strategy limited to 30 pages, a Resource Sharing Plan, and a Data Management and Sharing Plan. Key personnel requirements include a minimum of three person-months of effort for the PD/PI and a dedicated Project Manager committing at least four person-months. Additionally, awardees must implement a cybersecurity incident response plan with a 48-hour notification requirement for any discovered incidents.

National Institutes Of Health

POSTED

DEADLINE

Genomic Variant Interactions With Other Variants Or The Environment (UM1 Clinical Trials Not Allowed)

Solicitation # RFA-HG-27-009

Solicitation RFA-HG-27-009 is a Notice of Funding Opportunity from the National Institutes of Health, under the Department of Health and Human Services, for a UM1 Research Project with Complex Structure Cooperative Agreement. The program seeks to establish interaction centers to study how genetic or environmental interactions modify genomic variant impact as part of the second phase of the Impact of Genomic Variation on Function (IGVF) Consortium. Awardees must develop a quantitative research framework to detect joint effects beyond additive modifiers, apply genomic perturbation methods to collect phenotypic data, and share all resulting data, analyses, and predictive methods through the IGVF portal and catalog. The initiative is designed as discovery science to improve the understanding of genome-wide association studies and polygenic scores. Eligible applicants include small businesses and other for-profit organizations, with a maximum project period of five years and a budget limit of 1.5 million dollars in direct costs per year. Applications are due by December 14, 2026, and are evaluated via the NIH peer review system based on significance, contribution to consortium goals, and the rigor of the proposed research. Key requirements include a dedicated Project Manager devoting at least four person months and a PD/PI effort of at least three person months. Additionally, awardees must comply with strict cybersecurity incident reporting guidelines, maintain active SAM and eRA Commons registrations, and adhere to federal regulations regarding human subjects and vertebrate animal research.

National Institutes Of Health

POSTED

DEADLINE

Computational Modeling and Analysis of the Impact of Genomic Variation on Function (UM1, Clinical Trial Not Allowed)

Solicitation # RFA-HG-27-010

The National Institutes of Health, under the Department of Health and Human Services, is soliciting applications through RFA-HG-27-010 for the Computational Modeling and Analysis of the Impact of Genomic Variation on Function initiative. This UM1 Research Project with Complex Structure Cooperative Agreement seeks to establish centers that will join the Impact of Genomic Variation on Function (IGVF) Consortium. The primary objective is to develop, apply, and test interpretable computational models that utilize biological, biochemical, and biophysical mechanistic information to determine how genomic variation affects genome function and phenotypes related to human health. Awardees are expected to produce open-source software, models, and documentation, while sharing predictions and integrative analyses via the IGVF catalog and data portal. The maximum project period is five years, with application budgets limited to 800,000 dollars in direct costs. A critical requirement is that 20 percent of direct costs must be allocated annually to support collaborative work. Personnel requirements include a minimum aggregate effort of three person months for PD/PIs and a dedicated Project Manager devoting at least four person months. Applications are evaluated via the NIH peer review system based on significance, investigators, innovation, approach, and environment, with a focus on the likelihood of exerting a sustained influence on the research field. Eligible applicants include small businesses and other for-profit organizations, provided they maintain active SAM registration and a Unique Entity Identifier. All awards are administered under 42 CFR Part 52 and 2 CFR Part 200.

National Institutes Of Health

POSTED

DEADLINE

Cellular Senescence Network (SenNet): Discovery, Validation Centers (UM1 Clinical Trials Not Allowed)

Solicitation # RFA-RM-27-016

The National Institutes of Health is seeking applications for the Cellular Senescence Network Discovery and Validation Centers under solicitation RFA-RM-27-016. This initiative represents Stage 2 of the SenNet program, focusing on the definition, refinement, and validation of tissue- and disease-relevant cellular senescence signatures, known as senotypes, and their associated biomarkers. Selected centers will investigate the functional consequences of these signatures on human health and disease while generating high-quality molecular, cellular, and spatial datasets to be shared with the broader scientific community. Awardees are expected to utilize complementary experimental systems to validate biomarkers and analyze responses to senotherapeutic approaches or senescence-associated perturbations. In addition to research goals, applicants must propose specific aims for consortium-wide organizational and outreach activities. Interested parties must submit their responses by the deadline of November 24, 2026.

POSTED

DEADLINE

in about 1 month